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ABSTRACT
Homologous recombination (HR) is a major mech-
anism utilized to repair blockage of DNA replication
forks. Here, we report that a sister chromatid
exchange (SCE) generated by crossover-associated
HR efficiently occurs in response to replication fork
stalling before any measurable DNA double-strand
breaks (DSBs). Interestingly, SCE produced by rep-
lication fork collapse following DNA DSBs creation
is specifically suppressed by ATR, a central regula-
tor of the replication checkpoint. BRCA1 depletion
leads to decreased RPA2 phosphorylation (RPA2-P)
following replication fork stalling but has no obvious
effect on RPA2-P following replication fork collapse.
Importantly, we found that BRCA1 promotes RAD51
recruitment and SCE induced by replication fork
stalling independent of ATR. In contrast, BRCA1 de-
pletion leads to a more profound defect in RAD51
recruitment and SCE induced by replication fork
collapse when ATR is depleted. We concluded that
BRCA1 plays a dual role in two distinct HR-mediated
repair upon replication fork stalling and collapse.
Our data established a molecular basis for the ob-
servation that defective BRCA1 leads to a high sen-
sitivity to agents that cause replication blocks
without being associated with DSBs, and also impli-
cate a novel mechanism by which loss of cell cycle
checkpoints promotes BRCA1-associated tumori-
genesis via enhancing HR defect resulting from
BRCA1 deficiency.
INTRODUCTION
Homologous recombination (HR) promotes genome sta-
bility through the precise repair of DNA double-strand
breaks (DSBs) and other lesions that are encountered
during normal cellular replication (1). Although DNA
structures caused by replication arrest are the primary
substrate for HR in mitotic mammalian cells (2), the
precise functions of breast cancer suppression gene
BRCA1 in HR, particularly under replication stress,
remain largely unknown.
The repair mechanisms utilized by HR are different, de-
pending on the nature of the DNA structure (3–5). Two
ended DNA DSBs can be caused directly by ionizing ra-
diation (IR) or by restriction enzymes. One end DNA
breaks can occur indirectly as a result of discontinuities
of replication or when stalled replication forks are resolved
by endonucleases such as Mus81 (6,7). However, one
ended DNA DSBs could subsequently progress to two
ended DSBs due to a new origin ﬁre under conditions of
replication stress in mammalian cells (8). Alternatively,
ssDNA gaps are created without DSBs generation during
replication arrest (9). Two ended DNA DSBs in mamma-
lian cells trigger HR repair by short gene conversion (10),
whereas spontaneous HR or HR induced by replication
inhibition triggers a crossover event (2,11). In addition,
our recent publication demonstrated that phosphorylation
of RPA2, one subunit of ssDNA binding protein replica-
tion protein A (RPA), is speciﬁcally required for HR in
response to replication arrest but is not essential for the
HR induced by DSBs from I-Sce-I overexpression, further
supporting the notion that HR mechanisms triggered by
replication arrest differ from those involved in repairing
classical two ended DSBs (12).
The HR induced by two ended DSBs is initiated by a
generation of 30-ended single-strand DNA (ssDNA). CTIP
plays a critical regulatory role in ssDNA resection, along
with the Mre11 complex (13). Through the action of re-
combination mediator/comediator proteins, the RAD51
proteins displace RPA from ssDNA and form a RAD51
nucleoprotein ﬁlament (14). Holliday Junction (HJ) inter-
mediates resulting from RAD51 ﬁlament-dependent DNA
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resolved by gene conversion (non-crossover) or crossover.
However, non-crossover products is generated if invaded
ssDNA undergoes synthesis-dependent strand annealing
(SDSA) (15). The role of BRCA1 in HR induced by
DNA DSBs has been demonstrated previously (16–18).
Athough the precise molecular mechanisms by which
BRCA1 promotes HR are not clear it has been suggested
that BRCA1 might act as a mediator/comediator, which
facilitates displacement of RPA from ssDNA (19). In
addition, a recent study revealed that BRCA1 functions
in HR by promoting ssDNA resection via association with
CTIP (20). Particularly, several groups suggested a cross-
talk between 53BP1 and BRCA1 in ssDNA resection by
demonstrating that 53BP1 inhibits HR in BRCA1-
deﬁcient cells via a blocking resection of DNA breaks
(21–23).
The HR mechanisms required for repairing the lesions
caused by replication blockage remain poorly understood
in mammalian cells. It appears that similar to the
RuvABC complex in Escherichia coli (9), the endonuclease
Mus81 in mammalian cells contributes to replication re-
start by promoting HR via facilitation of one-ended DSB
generation (7,9). Interestingly, the one ended DSBs are
converted to two-ended DSBs due to new origins ﬁring
following replication blockage, which are repaired by
RAD51-mediated HR (8). However, HR-mediated repair
of DNA DSBs following replication collapse do not con-
tribute to restart of stalled replication forks (8). Although
the mechanisms causing this difference have not been
identiﬁed, it has been well established that HR repair fol-
lowing replication arrest is stimulated by collapsed DNA
replication forks when DSBs are generated (8,24).
The observation that HR defective cells are highly sen-
sitive to agents that cause replication blocks without being
associated with DSBs suggested that HR is also important
for the repair of lesions caused by stalled replication forks
(25,26). ssDNA is produced when replication forks are
stalled. In yeast, ssDNA-mediated HR is a mechanism
to repair stalled DNA replication forks (27). In addition,
the substrate for spontaneous sister chromatid recombin-
ation is more likely to be an ssDNA gap formed at a
stalled replication fork than a DSB (28). ssDNA gap
repair in E. coli requires RecA, a human equivalent of
RAD51, dependent HR in which gene conversion or cross-
over products are produced (9,29). In E. coli, ssDNA
resection is required to enlarge the ssDNA gap for
RAD51-dependent HR (30). Studies in mammalian cells
have shown the existence of ssDNA gaps during stalled
DNA replication (31,32) but it is not clear how these
lesions are repaired in mammalian cells. The observation
that BRCA1 is required for subnuclear assembly of
RAD51 and survival following treatment with a DNA
damaging agent that does not cause obvious DNA DSBs
(25,33) suggests that BRCA1 is involved in HR upon rep-
lication fork stalling. However, this idea has not been
tested.
An emerging concept in the ﬁeld is the continuous cross-
talk between HR and DNA damage checkpoint pathways.
DNA replication checkpoint suppresses HR by preventing
the formation of recombination foci in yeast (34–36). In
mammalian cells, the ATR- and Chk1-dependent check-
points prevent excessive formation of DNA DSBs, an im-
portant substrate for HR, during replication arrest
(37,38). It seems that similar control mechanisms exist in
both prokaryotic and eukaryotic cells. However, the ob-
servation that defects in ATR or Chk1 led to a deﬁcient
HR, using HR reporter, suggested that ATR/Chk1
promotes HR (39,40). Therefore, it has not been clear
how ATR regulates HR upon replication arrest in mam-
malian cells
Hydroxyurea (HU) has been used to cause either repli-
cation fork stalling or collapse by altering periods of HU
treatment (8). We determined the roles of BRCA1 in
HR-mediated repair in response to stalled or collapsed
DNA replication forks via different periods of HU treat-
ment by measuring sister chromatid exchange (SCE)
levels. Here, we report that SCE occurs before and after
the presence of any measurable DNA DSBs. BRCA1
plays a dual role in both types of SCE formation via regu-
lation of RAD51 recruitment. However, the role of
BRCA1 in SCE-associated HR in response to replication
fork collapse is suppressed by ATR. In addition, we report
that BRCA1 depletion leads to decreased RPA2-P upon
fork stalling but has no effect on RPA2-P following fork
collapse. We conclude that BRCA1 plays a dual role in
HR in two distinct HR repair upon replication fork
stalling and collapse.
MATERIALS AND METHODS
Plasmids, cell lines, infections and transfections
MCF-7, H1299 and MDA-MB-231 cells were obtained
from the American Type Culture Collection (Manassas,
VA, USA). The cells were grown in DMEM supplemented
with 10% FBS in a humidiﬁed atmosphere of 5% CO2 and
95% air at 37 C. BRCA1 short hairpin RNAs (shRNA)
were generated based on lentiviral pLKO.1-puro vector
(Sigma, St Louis, MO, USA). The oligonucleotides
BRCA1 is forward 50 CCGGCCCTAAGTTTACTTCTC
TAAAC TCGAGTTTAGAGAAGTAAACTTAGGGT
TTTTG 30 and reverse 50 AATTCAAAAACCCTAAGT
TTACTTCTCTAAACTCGAGTTTAGAGAAGTAAA
CTTAGGG—30. The oligonucleotides of a second
shRNA BRCA1 is forward 50 CCGGGCCCACCTAAT
TGTACTGAATCTCGAGATTCAGTACAATTAGGT
GGGCTTTTTG and reverse AATTCAAAAAGCCCAC
CTAATTGTACTGAATCTCGAGATTCAGTACAAT
TAGGTGGGC. The shRNA sequence targeting
non-coding regions of BRCA1 were annealed and cloned
into the AgeI and EcoRI sites of the Lentivirus transfer
pLKO.1-puro vector. The ATRsh and CTIPsh were
purchased from Sigma. All the DNA plasmid transfec-
tions were performed using Lipofectamine2000 according
to the manufacturer’s recommendations (Invitrogen,
Carlsbad, CA, USA).
Comet assay
The Neutral Comet Assay was performed using the Comet
Assay kit from Trevigen (Gaithersburg, MD, USA) fol-
lowing manufacturer’s instructions. The lyses occurred at
Nucleic AcidsResearch, 2012, Vol.40,No. 2 7274 C for 30min. Comets were analyzed using CometScore
software (TriTek, Sumerduck, VA, USA) (41).
SCE assay
The exponential cells were treated by HU (Hydroxyurea,
2mM, Sigma) for 6-h or 18-h, and further incubated with
BrdU (5mg/ml, Sigma) for another 50–60h. The colcemid
(0.1mg/ml, Gibco) was added into the cells for 4-h incu-
bation before ﬁxation onto the slides. Hoechst dye
(Invitrogen) and Giemsa (Gibco) were used for SCE
staining according to a standard procedure (42).
Immunoblotting and Immunoﬂuorescence analysis
The experiments were performed according to our
previous publications (12,41,43).
Real time PCR
CTIP forward primer: ACAGCTGAGGGAACAGCA
GAAA. CTIP reverse primer: TCTG CTGGAGTTGTT
CAGAAAGC. The second primer of CTIP is forward CT
ACGTCCACGTGAAAGTTTGG and reverse CCGGAT
CTATACTCCACTGGAT. Quantitative real time PCR
was performed according to the standard procedure.
Experiments were carried out in triplicate for each data
point.
HR assay
HR was measured in MCF7-pDR-GFP cells according to
previous publications (12,24,44). The cells with or without
ATR depletion were transfected with I-Sce-I expression
vector pCMV3xnls-1-SceI or a control vector or construct
pGFP, containing the full-length GFP cDNA, as a cali-
bration control for GFP-positive cells (45). For each
analysis, 20000 cells were processed and each experiment
was repeated three times.
Fluorescence in situ hybridization for chromosome
aberration analysis
Fluorescence in situ hybridization (FISH) was performed
using pan-telomeric peptide nucleic acid (PNA) probes.
Telomere (C3TA2)3-speciﬁc probe directly labeled with
Cy3 ﬂuorescent dyes were obtained from Applied
Biosystems (Foster City, CA, USA). The cells with or with-
out HU treatment were processed with FISH analysis 24-h
later according to previous publication (12,41).
Antibodies
Anti-BRCA1 (Santa Cruz, D-9), 1:200 dilutions for im-
munoﬂuorescence staining or western blotting; RAD51
(H92, Santa Cruz Technology), 1:300 dilutions for im-
munoﬂuorescence; RPA2-P (Bethyl Laboratories),1:200
for immunoﬂuorescence and at 1:1000 for immunoblot-
ting; Anti-phospho-H2AX (Upstate, 05-636),1:500 dilu-
tions for immunostaining; Anti-ATR (Santa Cruz,
G4),1:1000 for immunoblotting; Monoclonal antibody
RPA2 (EMD Bioscience Inc.), 1:200 for immuno-
ﬂuroscence staining or western Blot; Rabbit-anti-human
Phospho-Chk1 (Ser317, Cell Signaling), 1:1000 for
immunoblotting; Actin (Sigma), 1:5000 dilutions for im-
munoblotting; BrdU (Sigma), 1:100 dilution for
the immunostaining; anti-HA (covance) was used for im-
munoblotting at 1:1000. Secondary antibodies were
goat-anti-mouse IgG–HRP conjugated and goat-anti-
rabbit IgG–HRP conjugated both at 1:5000 dilutions for
immunobloting. Other secondary antibodies for immuno-
ﬂuorescence, goat–anti-mouse IgG Alexa Fluor 594 and
chicken-anti-rabbit IgG Alexa Fluor 488 (Molecular
Probe), were used at a concentration of 1:300 and 1:500,
respectively.
RESULTS
Frequencies of SCE increased following DNA replication
fork stalling or collapse
HU depletes the cells of dNTPs which initially results in
stalled replication forks that after prolonged treatment
collapse into DNA DSBs (8). We found no evidence of
DNA DSBs following 6-h HU treatment whereas DNA
breaks were obvious in MCF7 cells under 18-h of continu-
ous HU treatment by COMET assays (Figure 1A), con-
sisting with previous reports that prolonged HU treatment
could lead to collapse of stalled replication forks and for-
mation of DNA DSBs (8,24). Next, we determined if
stalled or collapsed DNA replication forks stimulate HR
Figure 1. SCE occurs following stalled or collapsed DNA replication forks. (A) The Comet assay was conducted in MCF7 cells treated with 2mM
HU. At least 150 cells were analyzed for each treatment. Results were expressed by Olive moment. P-values were calculated by Student’s t-test
(*P<0.01). (B) Representative SCEs. Arrows indicate the discontinuity in the staining pattern of the metaphase chromosomes due to SCEs. (C) The
levels of SCE in MCF7 cells with or without HU treatment. In brief, cells treated with 2mM HU for indicated periods of time were grown in the
presence of bromodeoxyuridine (BrdU) for 50–60h and mitotic cells were prepared according to a standard procedure (see ‘Materials and Methods’
section). Histograms show the frequency of SCE per 1000 chromosomes with at least 40–50 metaphase cells being counted. The data shown is the
result from three independent experiments. P-values were calculated by Student’s t-test (*P<0.01).
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over between two essentially identical DNA duplexes that
are generated when a chromosome undergoes DNA
replication (Figure 1B). We found that the rate of SCE
increased in MCF7 cells treated with HU for 6h
compared to control cells without HU treatment (Figure
1C), indicating that SCE-associated HR occurs following
DNA replication fork stalling before DNA DSBs
creation. We also found an increased frequency of SCE
following 18-h HU treatment when detectable DSBs are
created compared to untreated cells. Strikingly, the SCE
rate is not obviously elevated following 18-h HU treat-
ment in comparison to that associated with cells treated
with HU for 6-h (Figure 1C). To conﬁrm our result, we
determined the frequencies of SCE before and after DNA
DSBs generation following HU treatment in a second cell
line MDA-MB-231. No obvious DNA DSBs are observed
following 2- to 6-h HU treatment by Comet assay whereas
signiﬁcant DNA DSBs are detected following 18-h HU
treatment in MDA-MB-231 cells (Supplementary Figure
S1A). We found that the frequency of SCE induced by 4-h
HU treatment in MDA-MB-231 is elevated compared to
untreated cells. Similarly, the rate of SCE produced by
DSBs following 18-h HU treatment did not produce a
dramatic increase compared to that associated with 4-h
HU treatment (Supplementary Figure S1B). In
summary, the data illustrated in Figure 1 and
Supplementary Figure S1 suggest that stalled replication
forks can efﬁciently activate SCE before any detectable
DSBs during replication arrest.
It should be noted that the term of stalled replication
forks here represents a broader implication. A transient
phase when the structure and integrity of a replication fork
has been disrupted but a DNA DSB has not been created
is also included.
The SCE induced by replication fork collapse is
speciﬁcally inhibited by ATR
ATR-induced S phase cell cycle checkpoint has been sug-
gested to suppress HR by stabilizing replication forks and
preventing the generation of DNA DSBs (35). To test our
hypothesis that SCE induced by collapsed replication
forks would be blocked by an ATR-dependent cell cycle
checkpoint, we assessed SCE in cells depleted of ATR.
ATR was efﬁciently downregulated by lentiviral transduc-
tion with a shRNA (ATRsh) (Figure 2A). We found that
ATR depletion has no effect on the SCE induced by
stalled replication forks since a similar frequency of SCE
following 6-h HU treatment was observed in cells with a
proﬁcient or deﬁcient ATR (Figure 2B). The lack of effect
of ATR depletion on SCE induced by replication fork
stalling is not due to a lack of activation of cell cycle
checkpoint, since phosphorylation of Chk1 and RPA2,
two important downstream factors of ATR, are induced
in the cells treated with 6-h HU (Figure 2C). Conversely,
we found that SCE frequency is elevated in cells depleted
of ATR compared to those observed in control cells fol-
lowing 18-h HU treatment (Figure 2B). This observation
is in agreement with previous reports showing that ATR
suppresses HR protein foci (35,46). A representative
metaphase following 18-h HU treatment in cells depleted
of ATR is shown in Figure 2D. Although loss of ATR/
Chk1 resulted in increased DNA DSBs following replica-
tion arrest (8,35), the increased frequency of SCE in cells
depleted of ATR is unlikely to be a consequence of
increased amount of DSBs, due to the following
observation. We found that ATR knockdown by two in-
dependent shRNAs leads to a signiﬁcant reduction in HR
induced by DNA DSBs resulting from I-Sce-I endonucle-
ase overexpression using a DR-GFP HR reporter (12,45)
(Figure 2E), consistant with a previous report that ATR
kinase dead expression leads to inefﬁcient HR using the
same HR report (40). Our result was further conﬁrmed by
a second cells line, H1299 cells. With chromosomal inte-
gration of DR-GFP reporter (Supplementary Figure S2A
and B) (12), we found that depletion of ATR impaired HR
induced by I-Sce-I overexpression compared to control
cells. We do not think that the differences in frequencies
of HR in cells with or without ATR depletion are caused
by a variation of I-Sce-I expression because similar levels
of HA-I-Sce-I expression were observed under experimen-
tal conditions (Supplementary Figure S2C). Given the fact
that HR detected by DR-GFP HR reporter is the event
mediated by short tract gene conversion (47), our result
suggests that ATR promotes HR involved in short tract
gene conversion caused by DNA DSBs. We could not
exclude the possibility that gene conversion mediated by
long track is also regulated by ATR. In summary, we
conclude that SCE-associated HR following replication
fork collapse is speciﬁcally suppressed by ATR whereas
SCE-associated HR induced by replication fork stalling is
independent of ATR. In addition, HR involved in short
gene conversion is promoted by ATR.
The role of BRCA1 in facilitating SCE induced by
replication fork collapse is enhanced by ATR deﬁciency
We next determined how BRCA1 regulates SCE following
replication arrest. We ﬁrst established lentiviral (pLKO.1–
puro vector)-based constructs which target BRCA1
(BRCA1sh) (Figure 3A). We found that BRCA1 depletion
leads to a similar decrease in the frequency of SCE in cells
with proﬁcient or deﬁcient ATR following 6-h HU treat-
ment (Figure 3B). These results indicate that BRCA1
promotes HR following replication fork stalling independ-
ent of ATR. In contrast, BRCA1 differentially regulates
SCE produced by replication fork collapse in cells proﬁ-
cient or deﬁcient in ATR. We found that, in cells with a
proﬁcient ATR, BRCA1 knockdown has no obvious effect
on SCE following 18-h HU treatment compared to control
cells. However, in cells depleted of ATR, BRCA1 deple-
tion results in a decrease in the SCE rate compared to
control cells (Figure 3B). Similar results are obtained by
further categorizing the frequency of SCE into four classes
according to the number of SCE per metaphase (i.e.  9
versus 10–19 versus 20–29 versus  30 count per meta-
phase) (Figure 3C). In addition, our observation is
further conﬁrmed in MDA-MB-231 cells. We found that
BRCA1 knockdown causes a dramatic decrease in the rate
of SCE induced by 18-h HU treatment when ATR is
depleted. In contrast, BRCA1 knockdown leads to a
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independent of ATR depletion (Supplementary Figure
S3). Therefore, the data presented in Figure 3 and
Supplementary Figure S3 suggests that BRCA1
promotes SCE-associated HR upon replication fork
stalling, which is independent of ATR. In contrast,
BRCA1 plays a minor role in SCE-associated HR upon
replication fork collapse unless ATR is depleted. The dif-
ferential regulatory roles of ATR in BRCA1 dependent
SCE following replication fork stalling or collapse
support the notion that the molecular mechanism by
which BRCA1 promotes SCE associated HR following
replication fork stalling or collapse are distinct.
BRCA1 and RAD51 proteins are localized in ssDNA and
DNA DSB regions following DNA replication fork
stalling or collapse
RAD51 plays a key role in controlling SCE in DT40 cells.
In addition, overexpression of RAD51 leads to an
increased SCE event in Chinese hamster V79 cells
(48,49). The RAD51 form foci in response to DNA
damage and proteins accumulate at sites of ssDNA, sug-
gesting that RAD51 foci are sites of recombinational
DNA repair (50,51). Therefore, we next analyzed the
Rad51 foci upon replication arrest. We found that the
percentage of cells with RAD51 foci did not show an
obvious increase following 1- or 2-h HU treatment in
MCF7 cells (Figure 4A), which is similar to that observed
in U2OS cells (8). Interestingly, RAD51 form foci follow-
ing 6-h HU treatment although no obvious DSBs are
present at this time point (Figure 1A), which is consistent
with a previous report indicating that RAD51 foci is in-
dependent of DSBs (7). The formation of Rad51 foci fol-
lowing 6-h HU treatment is concurrent with ssDNA
generation since we have reported ssDNA regions are
generated at the same condition (12). RAD51 foci
became more evident following 18-h HU treatment
compared to that observed in cells treated with HU for
6h (Figure 4A) although the frequency of SCE in cells
Figure 2. ATR suppresses the SCE induced by replication fork collapse. (A) ATR knockdown by shRNA targeting ATR (ATRsh). Lysates were
prepared from MCF7 cells after 72-h infection with ATRsh or control shRNA (consh). (B) The SCEs induced by collapsed DNA replication forks
are suppressed by ATR. At 48-h after infection with ATRsh, MCF7 cells were used for SCE assay, which is performed as described in Figure 1C.
The data shown is the result from three independent experiments. P-values were calculated by Student’s t-test (*P<0.01). (C) Chk1 phosphorylation
(Chk1-P) and RPA2-P (anti-RPA2-p4/8 antibody) are increased in cells treated with 2mM HU for 6-h. Actin was detected as a load control.
(D) Representative metaphase prepared in MCF7 cells treated with 18-h HU following ATR depletion by ATRsh. The chromosomes with SCE(s)
were indicated by arrows. (E) ATR-deﬁcient cells show signiﬁcant reductions in HR mediated by short tract gene conversion. HR induced by I-Sce-I
was measured by dual-color ﬂow cytometric detection of GFP-positive cells. The relative HR frequencies in cells depleted of ATR are shown in
comparison to cells with intact ATR expression. Results are means from three independent experiments, with standard errors shown. P-values were
calculated by Student’s t-test (*P<0.01).
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in comparison to that associated with the cells treated with
HU for 6-h (Figure 1C). The main reason for this differ-
ence is due to the fact that RAD51 foci were determined
right after HU treatment. However the SCE assay was
conducted following 50–60h BrdU labeling and the cells
have to go through two cycles before the SCE assay.
Therefore, only the cells that went through two cell
cycles can be counted for SCE. A fraction of cells contain-
ing DSBs-induced RAD51 foci following 18-h HU treat-
ment might die before SCE assay due to an intact ATR
signaling. Alternatively, multiple subtypes of HR exist fol-
lowing replication collapse, all of which may involve
strand invasion and exchange steps in which RAD51
protein form foci. However, not all of these pathways ne-
cessarily result in SCE. For example, SDSA involves
strand exchange and invasion but only non-crossover
(gene conversion) products are formed (15).
In addition, the dynamic curve of BRCA1 foci in
response to HU is similar to that of RAD51
(Figure 4B). We found that both BRCA1 and RAD51
proteins are co-localized with ssDNA regions following
6-h HU treatment (Figure 4C, left panel), and both
proteins are co-localized with g-H2AX foci following
replication fork collapse (Figure 4C, right panel).
Although g-H2AX also form foci in the absence of
DNA DSBs, it is most likely that H2AX foci following
18-h HU treatment represent DNA DSBs because they
are detected by a comet assay at the same condition
(Figure 1A). In summary, we conclude that BRCA1 and
RAD51 proteins are recruited to ssDNA and DSBs
regions following replication fork stalling and collapse,
which supports the notion that these two proteins
function in HR-mediated repairs upon replication fork
stalling or collapse.
The function of BRCA1 in promotion of RAD51
recruitment upon replication fork collapse is
enhanced by ATR depletion
The role of BRCA1 in HR repair was initially proposed
based on its association with RAD51 (17). To clarify the
relationship between BRCA1 and RAD51 following rep-
lication fork stalling and collapse, we ﬁrst determined the
co-localization of these two proteins in response to stalled
and collapsed DNA replication forks. BRCA1 is
co-localized with RAD51 in the cells treated with 6- or
18-h HU, respectively (Figure 5A). To elucidate the mo-
lecular mechanisms behind SCE defects in cells with
Figure 3. The role of BRCA1 in promotion of SCE induced by replication fork collapse is enhanced by ATR depletion. (A) BRCA1 knockdown via
shRNA targeting BRCA1 (BRCA1sh) in MCF7 cells. (B) The roles of BRCA1 in SCE upon replication fork stalling and collapse are differentially
regulated by ATR depletion. The MCF7 cells were infected by consh, BRCA1sh, ATRsh or both of BRCA1sh and ATRsh. Forty-eight hours after
infection, the cells were treated with 2mM HU for indicated periods of time. The frequencies of SCE per 1000 chromosomes in cells treated with HU
are demonstrated. At least 40–50 metaphase cells are counted per group. Results are means from three independent experiments, with standard errors
shown. P-values were calculated by Student’s t-test (*P<0.01). (C) The histogram shows the fraction of metaphases with 1–9 versus 10–19 versus
20–29 versus  30 SCEs count.
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lates RAD51 foci in cells with or without ATR depletion.
We found that ATR depletion has no obvious effect on
RAD51 foci formation following 6-h HU treatment. In
contrast, ATR depletion leads to a signiﬁcant increase in
RAD51 foci formation following 18-h HU treatment
(Figure 5B), indicating that ATR inhibits RAD51 foci
induced by replication fork collapse. This result is con-
sistent with a previous report that ATR-deﬁcient cells
have increased RAD51 foci in response to replication
stress in MEF cells (46). We found that in cells with or
without depletion of ATR, the fraction of cells contain-
ing RAD51 foci induced by 6-h HU treatment markedly
decreased in cells with BRCA1 knockdown. However, we
found that BRCA1 knockdown leads to a greater
decrease in RAD51 foci formation induced by 18-h HU
treatment in cells depleted of ATR compared to the
control cells expressing intact ATR (Figure 5B).
Altogether, the results presented in Figure 5 suggests
that the role of BRCA1 in facilitating RAD51 foci
upon replication fork stalling is independent of ATR
but the role of BRCA1 in promoting RAD51 recruitment
upon replication fork collapse is enhanced by ATR
depletion, in line with the observation illustrated in
Figure 3B that the role of BRCA1 in SCE are differen-
tially regulated by ATR depletion. We conclude that
BRCA1 plays a role in efﬁcient RAD51 recruitment in
response to replication fork stalling and collapse. The
deﬁciency in RAD51 recruitment due to BRCA1 deple-
tion upon replication fork collapse was ampliﬁed by
ATR depletion. This data further support the idea that
molecular mechanisms by which BRCA1 promotes HR
following replication fork stalling and collapse are
different.
BRCA1 depletion leads to decreased RPA2-P in response
to replication fork stalling but has no effect on RPA2-P
upon replication fork collapse
We have reported that RPA2-P is required for HR in
response to replication arrest (12). BRCA1 is important
for ssDNA resection (20). Thus, we next determined
RPA2-P levels in cells with or without BRCA1
knockdown. We found that BRCA1 depletion leads to de-
creased RPA2-P levels by immunoblotting in cells follow-
ing 6-h HU treatment, suggesting that BRCA1 promotes
ssDNA resection following replication fork stalling
(Figure 6A). However, BRCA1 depletion appears to
have no obvious effect on RPA2-P foci formation
because a similar fraction of cells containing RPA2-P
foci was observed in cells proﬁcient or deﬁcient in
BRCA1 in response to 6-h HU treatment (Figure 6B).
The discrepancy between RPA2-P protein levels and
RPA2-P foci is probably caused by the fact that RPA
foci formation requires several kilobases of ssDNA, and
thus the alteration in RPA2-P coated ssDNA may not
be detected by immunoﬂuorescence staining (8).
Figure 4. BRCA1 and RAD51 proteins are localized at DNA ssDNA or DSBs region in response to stalled or collapsed DNA replication forks.
(A and B). Kinetics of RAD51 (A) or BRCA1 (B) focus formation. The percentage of cells with more than 10 nuclear foci was calculated. In each
experiment, 200 nuclei were counted per data point. Error bars indicate standard errors from three independent experiments (*P<0.01). (C) BRCA1
and RAD51 colocalizes at the ssDNA region in response to replication fork stalling (left panel). The protocol for ssDNA detection has been
described in a previous publication (12,51). Cells treated with 6-h HU were co-stained by anti-BrdU antibody and antibody against RAD51 or
BRCA1. Representative foci images in response to 6-h HU treatment were shown. BRCA1 and RAD51 protein colocalizes at DSBs region in
response to replication fork collapse (right panel). The cells co-stained with anti-g-H2AX antibodies and antibodies against RAD51 or BRCA1.
Representative foci images in response to 18-h HU treatment were shown.
732 Nucleic Acids Research, 2012,Vol. 40,No. 2Interestingly, we found that BRCA1 depletion has no
obvious effect on both RPA2-P protein levels and foci
formation following 18-h HU treatment (Figure 6A and
B), indicating that the molecular mechanism by which
BRCA1 promotes HR upon replication fork stalling and
collapse are distinct. To further test our hypothesis that
the ssDNA resection is required for BRCA1-dependent
HR following replication fork stalling and collapse, we
determined how CTIP regulates SCE. CTIP was efﬁciently
downregulated by shRNA targeting CTIP (Figure 6C).
We found that CTIP knockdown leads to decreased fre-
quency of SCE following replication fork stalling, which is
independent of ATR. In contrast, the CTIP knockdown
leads to an obviously decreased SCE frequency in cells
depleted of ATR after 18-h HU treatment although it
has a minor effect on SCE formation in cells with intact
ATR expression (Figure 6D). This result is similar to that
observed in cells with BRCA1 knockdown (Figure 3B),
indicating that CTIP functions in the same pathway as
BRCA1. In summary, the data illustrated in Figure 6
suggests that BRCA1 depletion leads to a decreased
RPA2-P following replication fork stalling but has no
obvious effect on RPA2-P following replication fork
collapse. In addition, BRCA1 promotes ssDNA resection
along with CTIP in response to replication fork stalling
and collapse.
BRCA1 is critical for maintaining genomic integrity
following replication fork stalling
We have found that BRCA1 is required for SCE follow-
ing replication fork stalling before DSBs are produced
(Figure 3B). We anticipate that BRCA1 knockdown
leads to accumulated ssDNA following replication fork
stalling. However, BRCA1 depletion appears to have no
obvious effect on RPA2 foci formation induced by 6-h
HU treatment (Supplementary Figure S4). This is most
likely caused by the following two reasons. First, as we
discussed previously, the immunoﬂuorescence may not be
able to detect the accumulated ssDNA due to the limita-
tion of this assay. Second, unrepaired ssDNA upon repli-
cation fork stalling is not stable and will be targeted by
nucleases, which subsequently leads to DNA DSBs (9).
Therefore, the unrepaired ssDNA due to a BRCA1
defect are most likely converted into DSBs. To test this
hypothesis, we determined the effect of BRCA1
knockdown on chromatid breaks and chromosome
breaks following replication fork stalling, using FISH
assay. As expected, cells depleted of BRCA1 by shRNA
displayed higher frequencies of chromatid and chromo-
some breaks after 6-h HU treatment although no detect-
able breaks are found in control cells (Figure 7A and B).
Most importantly, in BRCA1 deﬁcient cells, 6-h HU treat-
ment leads to increased radial structures (Figure 7C)
which are generated by the increased frequency of chro-
matid breaks and subsequent inter-chromatid fusions. The
representative chromosome abnormalities induced by 6-h
HU treatment in cells with BRCA1 knockdown are
demonstrated in Figure 7D. Moreover, both the
frequencies of chromatid breaks (Figure 7A) and chromo-
some breaks (Figure 7B) are not obviously increased
in control cells treated with 6-h HU treatment compared
to the untreated cells, further conﬁrming the results
obtained using a comet assay that no detectable DSBs
are present in cells with 6-h HU treatment (Figure 1A).
The result from a second repeat was also presented in
Supplementary Figure S5. In summary, we concluded
that function of BRCA1 in HR induced by replication
fork stalling is critical for maintaining genomic stability
following replication fork stalling.
DISCUSSION
Previous studies have revealed that BRCA1 functions in
HR induced by DNA DSBs. However, how BRCA1 func-
tions in HR in response to replication blockages remains
poorly understood. Here, we report the existence of two
distinct SCE-associated HR repair pathways. One occurs
Figure 5. The roles of BRCA1 in promoting RAD51 recruitment induced by replication fork collapse are enhanced by ATR depletion. (A) BRCA1
and Rad51 colocalizes in response to replication fork stalling and collapsed. (B) The roles of BRCA1 in Rad51 recruitment upon replication fork
stalling and collapse are differentially regulated by ATR depletion. Exponentially growing MCF7 cells were ﬁrst infected with both of BRCA1sh and
ATRsh. Forty-eight hours after infection, the cells treated with HU were ﬁxed at indicated time points. Then the ﬁxed cells were detected for RAD51
by immunostaining. The data are from three independent experiments. Y-axis represents the percentage cell with positive foci. Cells were scored
positive when 10 nuclear foci were visible. Results are means from three independent experiments, with standard errors shown. P-values were
calculated by Student’s t-test (*P<0.01).
Nucleic AcidsResearch, 2012, Vol.40,No. 2 733Figure 6. BRCA1 depletion leads to decreased RPA2-P protein levels following replication fork stalling but has no effect on RPA2 protein levels
following replication fork collapse. (A) Immunoblot analysis of RPA2-P expression in MCF7 cells with or without BRCA1 depletion before and after
2mM HU treatment for 6-h or 18-h. Proteins were visualized by immunoblot with anti-RPA2-p4/8, or anti-RPA2 antibody. (B) RPA2-P foci in cells
with or without BRCA1 depletion. Fixed cells were stained by anti-RPA2-p4/8 antibody. Cells were scored positive when 10 nuclear foci were visible.
Data were collected from three independent experiments, and the mean with standard errors was calculated. P-value was calculated by Student’s
t-test (P>0.05). (C) CTIP was downregulated by shRNA targeting CTIP (CTIPsh). The CTIP mRNA was ampliﬁed by real-time quantitative PCR.
mRNA CTIP in cells with or without CTIPsh infection were presented as a relative value compared to control cells infected with consh. Data were
collected from three independent experiments. P-values were calculated by Student’s t-test (*P<0.01). (D) CTIP knockdown results in a more
profound defect in SCE induced by 18-h HU treatment when ATR is depleted compared to cells with intact ATR expression. The SCE assays were
performed as described in Figure 1C. Results are means from three independent experiments, with standard errors shown (*P<0.01,
#P<0.05).
P-values were calculated by Student’s t-test.
Figure 7. BRCA1 knockdown leads to increased frequencies of chromosome aberrations following replication fork stalling. (A–C) Frequencies of
chromatid breaks (A) and chromosome breaks (B) and radial structure (C) in MCF7 cells. For each sample 40–50 metaphases were analyzed. The
data shown are from one of two independent experiments. (D)The representative metaphase spreads following 6-h HU treatment in MCF7 cells
depleted of BRCA1 are shown. FISH using telomeric probe reveals the pink color. Chromosomes were stained with DAPI (blue).
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the other take place after DSB creation when replication
fork collapse. ATR speciﬁcally suppresses SCE-associated
HR induced by replication fork collapse but has no role
on the SCE-associated HR following replication fork
stalling. BRCA1 promotes these two distinct HR
pathways but the role of BRCA1 in promotion of
SCE-associated HR upon replication fork collapse is sup-
pressed by ATR (Figure 8).
Both stalled and collapsed DNA replication forks
stimulate SCE-associated HR in mammalian cells
Consistent with earlier reports (8,24) we found that HR-
mediated repair takes place when replication fork progress
collapses. However, unprecedentedly, our present study
shows that SCE-associated HR efﬁciently occurs before
DSBs are detectable (Figure 1), which is different to the
previous reports that replication arrest induced HR is trig-
gered when DNA DSBs are generated using HR reporter
assays (8,24). Our results provide molecular basis for the
observation that BRCA1 deﬁciency leads to an enhanced
sensitivity to chemotherapeutic drugs that cause replica-
tion blockage without being associated with DSBs (25,33).
Recombination-related processes have a central function
in the recovery of stalled or collapsed replication forks in
bacteria (9). The importance of recombination-mediated
fork restart mechanisms remains to be established in eu-
karyotic cells. Thus, it would be interesting to know
whether the role of BRCA1 in HR upon replication fork
stalling or collapse in mammalian cells contributes to the
replication fork recovery.
ATR differentially controls SCE upon replication fork
stalling or collapse
We found that SCE-associated HR upon replication fork
collapse is blocked by ATR, an essential regulator for cell
cycle checkpoints during replication arrest. However,
SCE-associated HR occurring following replication fork
stalling is independent of ATR (Figure 2). The question
raised by our study is why ATR differentially controls
SCE-associated HR during replication fork stalling and
collapse. The primary means of repairing ssDNA gaps
following replication fork stalling is by HR, which uses
complementary DNA from the sister chromatid (52,53).
This process is inherently error-free compared to other
mechanisms, such as error-prone translesion polymerases
(53). In contrast, DSB creations are involved during repair
of collapsed DNA replication forks by HR, which may
cause a consequence of genomic instability due to illegit-
imate recombination, such as non-homologous end
joining. Therefore, HR repair in response to replication
fork collapse is suppressed by ATR. Alternatively, a lack
of substrates for ATR during replication fork stalling may
be one of the reasons. HR repression by ATR operates at
least in part, by impeding the resection of cutting free
DNA ends (35). There are not obvious free DNA DSB
ends present at the site of replication fork stalling. Hence,
it is not surprising that SCE-associated HR following
forks collapse before DSBs are generated is not affected
by the ATR status.
Our data revealed that ATR promotes DSBs induced
HR involving short track gene conversion (Figure 2E,
Supplementary Figure S2) although ATR suppresses
SCE-associated HR following replication fork collapse.
Figure 8. A dual role of BRCA1 in two distinct HR mediated repairs in response to replication arrest. BRCA1 promotes ssDNA gap repair by HR
independent of ATR. In addition, BRCA1 facilitates the repair of DNA DSBs following replication fork collapse, which is suppressed by ATR.
BRCA1 perhaps functions with CTIP in promoting ssDNA resection at stalling replication forks. However, BRCA1 promotes HR following
replication fork collapse via multiple mechanisms, in which BRCA1 acts as a HR mediator/comediator and also facilitates ssDNA resection
along with CTIP.
Nucleic AcidsResearch, 2012, Vol.40,No. 2 735These results indicate that subtypes of HR are differently
regulated by ATR. HR is a typical error-free repair mech-
anism. However, inappropriate HR events can have dele-
terious consequences by causing loss of heterozygosity
(LOH) and chromosome translocations. Therefore, HR
must be tightly regulated (15). Although error free HR
involving gene conversion is favorably operated in unchal-
lenged cells (10), it may not be the case when the cells lose
ATR signaling. SCE-associated HR is perhaps a backup
mechanism to repair DNA DSBs when the cells with a
defective checkpoint signaling are challenged by replica-
tion stress. To repair overwhelmingly increased DNA
DSBs due to loss of checkpoint signaling, all potential
HR mechanisms, including SCE-associated HR, would
be activated, particularly when gene conversion-mediated
HR is compromised. Hence, SCE-associated HR is more
evident when ATR signaling is defective. Alternatively,
loss of checkpoint signaling by disruption of ATR leads
to a defect in phosphorylation of downstream factor(s)
controlling the balance between gene conversion- and
crossover-associated HR. Future studies would be
required to address the molecular mechanisms associated
with differential regulation by ATR in subtypes of HR
following replication fork collapse.
BRCA1 deﬁciency leads to an enhanced HR defect when
ATR is hindered
Our study demonstrates that BRCA1 plays a role in
SCE-associated HR following replication fork stalling
(Figure 3), which contributes to maintenance of genomic
stability (Figure 7). Our work provides the evidence sup-
porting the observation that defective BRCA1 leads to be
highly sensitive to agents that cause replication arrest
without being associated with DSBs. In addition,
BRCA1 also promotes SCE upon replication fork
collapse when DSBs are generated. However, this mech-
anism is suppressed by ATR (Figure 3). The function of
BRCA1 in SCE-mediated HR following replication fork
collapse is ampliﬁed when upstream DNA checkpoint sig-
naling is hindered. This ﬁnding is of utmost importance
because it provides a novel mechanism by which loss of
cell cycle checkpoints promotes BRCA1-associated
tumorigenesis. Mutations in checkpoint pathways can
enhance the likelihood of malignant transformation by
permitting the continued growth of cells with genomic
abnormalities (54). There is no exception for BRCA1-
associated tumorigenesis (55–57). ATR was found
downregulated in BRCA1 mutation carriers (58). Thus,
it is possible that loss of ATR or other cell cycle check-
point proteins amplify the phenotypes due to BRCA1
mutation in addition to permitting survival of cells with
a BRCA1 mutant. This could be an alternate molecular
mechanism explanation of why mutations in a second gene
required for cell cycle checkpoints is required for BRCA1-
associated cancer development.
BRCA1 promotes SCE-associated HR upon replication
fork stalling and collapse via distinct mechanisms
Of note, our results point to distinct molecular mechan-
isms by which BRCA1 facilitates SCE- associated HR in
response to replication fork stalling or collapse based on
the following three reasons (Figures 4–6). First, the DNA
substrates for SCE-associated HR are different, which are
associated with or without DSBs, respectively. Second, the
functions of BRCA1 in SCE-associated HR following
replication fork stalling and collapses are differentially
regulated by ATR deﬁciency. Third, BRCA1 differentially
regulates RPA2-P before or after the presence of DSBs
in response to replication arrest, in which BRCA1 deple-
tion leads to an impaired RPA2-P in response to
replication fork stalling but has no obvious impact on
RPA2-P induced by fork collapse (Figure 6A). The
defect of RPA2-P induced by fork stalling in cells with a
defective BRCA1 could be caused by an impaired ssDNA
resection. RPA2-P occurs when RPA binds to elongated
ssDNA and is dependent on the length of ssDNA (59).
BRCA1 perhaps functions in ssDNA resection at the
stalled replication forks along with CTIP. Although
direct evidence indicating that BRCA1/CTIP promotes
ssDNA resection at the site of replication fork stalling
without being associated with free DNA end has not
been reported, it has been demonstrated that the ssDNA
gap is required for enlargement by the 50–30 exonuclease
before HR in bacteria (30). In contrast to a sole role in
DSBs end resection by BRCA1 upon replication fork
stalling, BRCA1 perhaps functions in HR when replica-
tion fork collapses via multiple mechanisms. BRCA1 acts
as a mediator/comediator of HR to promote displacement
of RPA from ssDNA in addition to enhancing ssDNA
resection (Figures 7 and 8). The likely scenario following
replication fork collapse is that BRCA1 deﬁciency is
supposed to incur a reduced level of RPA2-P due to im-
pairment in ssDNA resection. However, on the other
hand, BRCA1 also functions as a mediator/comediator
of RAD51. The defect in BRCA1 could also cause an
increase in RPA2-P levels due to a failure of displacement
of RPA from ssDNA. This bidirectional regulation by
BRCA1 depletion may not necessarily cause an obvious
alteration in RPA2-P levels upon replication fork collapse
(Figures 6 and 8).
The question as to why BRCA1 plays a profound role
in SCE-associated HR in cells with ATR deﬁciency fol-
lowing replication fork collapse has not been made clear.
One possibility is that, as we discussed above, the SCE-
mediated repair pathway may became more important
when the cells lacking checkpoints are challenged by rep-
lication arrest. Therefore, the role of BRCA1 in SCE-
associated HR is not evident unless ATR is depleted.
Alternatively, loss of ATR may provide substrates for
efﬁcient function of BRCA1 in HR. BRCA1 promotes
repair of DSBs following replication forks collapse via
multiple mechanisms whereas BRCA1 promotes HR fol-
lowing replication fork stalling solely via the facilitation of
ssDNA resection (Figure 8). Last, ATR plays a direct role
in BRCA1-dependent SCE following replication fork
collapse via phosphorylation of BRCA1. The ATR gene
has been linked with BRCA1 by the evidence that ATR
phosphorylates BRCA1 (60). However, it is unclear how
ATR-dependent phosphorylation of BRCA1 alters BRCA1
activity in HR under replication stresses, which would be
an interesting question to be addressed in the future.
736 Nucleic Acids Research, 2012,Vol. 40,No. 2In conclusion, two distinct SCE-associated HR occur
following replication fork stalling and collapse. SCE-
associated HR upon replication fork collapse when DSB
is created is suppressed by ATR. BRCA1 promotes
SCE-associated HR upon replication fork stalling regard-
less of ATR deﬁciency but the role of BRCA1 in SCE-
associated HR upon replication fork collapse is enhanced
by ATR defect. Our study provides a novel mechanism by
which loss of cell cycle checkpoints promotes BRCA1-
associated tumorigenesis via ampliﬁcation of HR defect.
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